296 related articles for article (PubMed ID: 22291217)
1. An evaluation of the impact of MAPT, SNCA and APOE on the burden of Alzheimer's and Lewy body pathology.
Wider C; Ross OA; Nishioka K; Heckman MG; Vilariño-Güell C; Jasinska-Myga B; Erketin-Taner N; Rademakers R; Graff-Radford NR; Mash DC; Papapetropoulos S; Duara R; Uchikado H; Wszolek ZK; Farrer MJ; Dickson DW
J Neurol Neurosurg Psychiatry; 2012 Apr; 83(4):424-9. PubMed ID: 22291217
[TBL] [Abstract][Full Text] [Related]
2. The effect of MAPT haplotype on neocortical Lewy body pathology in Parkinson disease.
Robakis D; Cortes E; Clark LN; Vonsattel JP; Virmani T; Alcalay RN; Crary JF; Levy OA
J Neural Transm (Vienna); 2016 Jun; 123(6):583-8. PubMed ID: 27098667
[TBL] [Abstract][Full Text] [Related]
3. Tau pathology in the olfactory bulb correlates with Braak stage, Lewy body pathology and apolipoprotein epsilon4.
Tsuboi Y; Wszolek ZK; Graff-Radford NR; Cookson N; Dickson DW
Neuropathol Appl Neurobiol; 2003 Oct; 29(5):503-10. PubMed ID: 14507342
[TBL] [Abstract][Full Text] [Related]
4. Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis.
Irwin DJ; Grossman M; Weintraub D; Hurtig HI; Duda JE; Xie SX; Lee EB; Van Deerlin VM; Lopez OL; Kofler JK; Nelson PT; Jicha GA; Woltjer R; Quinn JF; Kaye J; Leverenz JB; Tsuang D; Longfellow K; Yearout D; Kukull W; Keene CD; Montine TJ; Zabetian CP; Trojanowski JQ
Lancet Neurol; 2017 Jan; 16(1):55-65. PubMed ID: 27979356
[TBL] [Abstract][Full Text] [Related]
5. Association of MAPT H1 subhaplotypes with neuropathology of lewy body disease.
Heckman MG; Kasanuki K; Brennan RR; Labbé C; Vargas ER; Soto AI; Murray ME; Koga S; Dickson DW; Ross OA
Mov Disord; 2019 Sep; 34(9):1325-1332. PubMed ID: 31234228
[TBL] [Abstract][Full Text] [Related]
6. Lewy body variant of Alzheimer's disease or cerebral type lewy body disease? Two autopsy cases of presenile onset with minimal involvement of the brainstem.
Yokota O; Tsuchiya K; Uchihara T; Ujike H; Terada S; Takahashi M; Kimura Y; Ishizu H; Akiyama H; Kuroda S
Neuropathology; 2007 Feb; 27(1):21-35. PubMed ID: 17319280
[TBL] [Abstract][Full Text] [Related]
7. Regional Overlap of Pathologies in Lewy Body Disorders.
Colom-Cadena M; Grau-Rivera O; Planellas L; Cerquera C; Morenas E; Helgueta S; Muñoz L; Kulisevsky J; Martí MJ; Tolosa E; Clarimon J; Lleó A; Gelpi E
J Neuropathol Exp Neurol; 2017 Mar; 76(3):216-224. PubMed ID: 28395086
[TBL] [Abstract][Full Text] [Related]
8. MAPT H1 haplotype is associated with enhanced α-synuclein deposition in dementia with Lewy bodies.
Colom-Cadena M; Gelpi E; Martí MJ; Charif S; Dols-Icardo O; Blesa R; Clarimón J; Lleó A
Neurobiol Aging; 2013 Mar; 34(3):936-42. PubMed ID: 22819391
[TBL] [Abstract][Full Text] [Related]
9. A cytosine-thymine (CT)-rich haplotype in intron 4 of SNCA confers risk for Lewy body pathology in Alzheimer's disease and affects SNCA expression.
Lutz MW; Saul R; Linnertz C; Glenn OC; Roses AD; Chiba-Falek O
Alzheimers Dement; 2015 Oct; 11(10):1133-43. PubMed ID: 26079410
[TBL] [Abstract][Full Text] [Related]
10. Lewy body-related alpha-synucleinopathy in the aged human brain.
Jellinger KA
J Neural Transm (Vienna); 2004 Oct; 111(10-11):1219-35. PubMed ID: 15480835
[TBL] [Abstract][Full Text] [Related]
11. The genetic contributions of SNCA and LRRK2 genes to Lewy Body pathology in Alzheimer's disease.
Linnertz C; Lutz MW; Ervin JF; Allen J; Miller NR; Welsh-Bohmer KA; Roses AD; Chiba-Falek O
Hum Mol Genet; 2014 Sep; 23(18):4814-21. PubMed ID: 24777780
[TBL] [Abstract][Full Text] [Related]
12. Lysosomal cathepsin D is upregulated in Alzheimer's disease neocortex and may be a marker for neurofibrillary degeneration.
Chai YL; Chong JR; Weng J; Howlett D; Halsey A; Lee JH; Attems J; Aarsland D; Francis PT; Chen CP; Lai MKP
Brain Pathol; 2019 Jan; 29(1):63-74. PubMed ID: 30051532
[TBL] [Abstract][Full Text] [Related]
13. ADNC-RS, a clinical-genetic risk score, predicts Alzheimer's pathology in autopsy-confirmed Parkinson's disease and Dementia with Lewy bodies.
Dai DL; Tropea TF; Robinson JL; Suh E; Hurtig H; Weintraub D; Van Deerlin V; Lee EB; Trojanowski JQ; Chen-Plotkin AS
Acta Neuropathol; 2020 Oct; 140(4):449-461. PubMed ID: 32749525
[TBL] [Abstract][Full Text] [Related]
14. APOE4 exacerbates α-synuclein seeding activity and contributes to neurotoxicity in Alzheimer's disease with Lewy body pathology.
Jin Y; Li F; Sonoustoun B; Kondru NC; Martens YA; Qiao W; Heckman MG; Ikezu TC; Li Z; Burgess JD; Amerna D; O'Leary J; DeTure MA; Zhao J; McLean PJ; Dickson DW; Ross OA; Bu G; Zhao N
Acta Neuropathol; 2022 Jun; 143(6):641-662. PubMed ID: 35471463
[TBL] [Abstract][Full Text] [Related]
15.
Dickson DW; Heckman MG; Murray ME; Soto AI; Walton RL; Diehl NN; van Gerpen JA; Uitti RJ; Wszolek ZK; Ertekin-Taner N; Knopman DS; Petersen RC; Graff-Radford NR; Boeve BF; Bu G; Ferman TJ; Ross OA
Neurology; 2018 Sep; 91(12):e1182-e1195. PubMed ID: 30143564
[TBL] [Abstract][Full Text] [Related]
16. Confluence of α-synuclein, tau, and β-amyloid pathologies in dementia with Lewy bodies.
Colom-Cadena M; Gelpi E; Charif S; Belbin O; Blesa R; Martí MJ; Clarimón J; Lleó A
J Neuropathol Exp Neurol; 2013 Dec; 72(12):1203-12. PubMed ID: 24226269
[TBL] [Abstract][Full Text] [Related]
17. Lewy body-related alpha-synucleinopathy in aging.
Saito Y; Ruberu NN; Sawabe M; Arai T; Kazama H; Hosoi T; Yamanouchi H; Murayama S
J Neuropathol Exp Neurol; 2004 Jul; 63(7):742-9. PubMed ID: 15290899
[TBL] [Abstract][Full Text] [Related]
18. Genetic association between the APOE*4 allele and Lewy bodies in Alzheimer disease.
Tsuang DW; Wilson RK; Lopez OL; Luedecking-Zimmer EK; Leverenz JB; DeKosky ST; Kamboh MI; Hamilton RL
Neurology; 2005 Feb; 64(3):509-13. PubMed ID: 15699383
[TBL] [Abstract][Full Text] [Related]
19. Cortical Lewy bodies and Aβ burden are associated with prevalence and timing of dementia in Lewy body diseases.
Ruffmann C; Calboli FC; Bravi I; Gveric D; Curry LK; de Smith A; Pavlou S; Buxton JL; Blakemore AI; Takousis P; Molloy S; Piccini P; Dexter DT; Roncaroli F; Gentleman SM; Middleton LT
Neuropathol Appl Neurobiol; 2016 Aug; 42(5):436-50. PubMed ID: 26527105
[TBL] [Abstract][Full Text] [Related]
20. Cellular co-localization of phosphorylated tau- and NACP/alpha-synuclein-epitopes in lewy bodies in sporadic Parkinson's disease and in dementia with Lewy bodies.
Arima K; Hirai S; Sunohara N; Aoto K; Izumiyama Y; Uéda K; Ikeda K; Kawai M
Brain Res; 1999 Oct; 843(1-2):53-61. PubMed ID: 10528110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
